NYSE:IVC - New York Stock Exchange, Inc. - US4612031017 - Common Stock - Currency: USD
0.6598
-0.02 (-2.25%)
The current stock price of IVC is 0.6598 USD. In the past month the price increased by 57.1%. In the past year, price decreased by -69.17%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27 | 223.81B | ||
ISRG | INTUITIVE SURGICAL INC | 73.82 | 202.13B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.13 | 152.27B | ||
SYK | STRYKER CORP | 30.93 | 147.92B | ||
MDT | MEDTRONIC PLC | 15.94 | 109.16B | ||
BDX | BECTON DICKINSON AND CO | 12.44 | 50.35B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.04 | 44.39B | ||
IDXX | IDEXX LABORATORIES INC | 44.66 | 41.26B | ||
RMD | RESMED INC | 27.27 | 36.31B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 16.05 | 33.80B | ||
DXCM | DEXCOM INC | 50.98 | 32.98B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.04 | 22.77B |
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. The company is headquartered in Elyria, Ohio and currently employs 3,000 full-time employees. The firm provides clinically complex medical device solutions for congenital, acquired and degenerative conditions. Its segments include North America and Europe. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, seating and positioning products and power add-ons. Its lifestyle products include pressure relieving sleep surfaces, safe patient handling, beds, manual wheelchairs and personal care products. Its respiratory therapy products include stationary oxygen concentrators, portable oxygen concentrators and oxygen refilling devices. The company also offers repair services, equipment rentals and external contracting. The company sells its products to home medical equipment providers, through retail and e-commerce channels, residential care operators, dealers and government health services.
INVACARE CORP
P O Box 4028, One Invacare Way
Elyria OHIO 44035 US
CEO: Matthew E. Monaghan
Employees: 3000
Phone: 14403296000.0
The current stock price of IVC is 0.6598 USD. The price decreased by -2.25% in the last trading session.
The exchange symbol of INVACARE CORP is IVC and it is listed on the New York Stock Exchange, Inc. exchange.
IVC stock is listed on the New York Stock Exchange, Inc. exchange.
6 analysts have analysed IVC and the average price target is 1.68 USD. This implies a price increase of 155.08% is expected in the next year compared to the current price of 0.6598. Check the INVACARE CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INVACARE CORP (IVC) has a market capitalization of 24.91M USD. This makes IVC a Nano Cap stock.
INVACARE CORP (IVC) currently has 3000 employees.
INVACARE CORP (IVC) has a support level at 0.41 and a resistance level at 0.74. Check the full technical report for a detailed analysis of IVC support and resistance levels.
The Revenue of INVACARE CORP (IVC) is expected to decline by -16.76% in the next year. Check the estimates tab for more information on the IVC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IVC does not pay a dividend.
INVACARE CORP (IVC) will report earnings on 2023-03-06, after the market close.
INVACARE CORP (IVC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.04).
ChartMill assigns a technical rating of 4 / 10 to IVC. When comparing the yearly performance of all stocks, IVC is a bad performer in the overall market: 91.81% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to IVC. IVC has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months IVC reported a non-GAAP Earnings per Share(EPS) of -2.04. The EPS decreased by -137.21% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | N/A | ||
ROE | N/A | ||
Debt/Equity | 4.82 |
ChartMill assigns a Buy % Consensus number of 83% to IVC. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -309.94% and a revenue growth -16.76% for IVC